Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;56(1):79-81.
doi: 10.4103/0019-5545.124721.

Methylphenidate and suicidal ideation: Report of two cases

Priti Arun  1 , Sukhtej Sahni  1
Affiliations

Methylphenidate and suicidal ideation: Report of two cases

Priti Arun et al. Indian J Psychiatry. 2014 Jan.

Abstract

Stimulant prescriptions are routinely used to treat Attention Deficit Hyperactivity Disorder. Reports of psychiatric symptoms that have occurred include euphoria, delirium, confusion, toxic psychosis, and hallucinations. Here, authors report two cases of Attention Deficit Hyperactivity Disorder who were prescribed methylphenidate. Both children developed suicidal ideation that abated after discontinuing the drug. There were no depressive symptoms reported along with it, and the ideation could not be explained on the basis of impulsivity either.

Keywords: Attention deficit hyperactivity disorder; children; methylphenidate suicidal ideas.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Challman TD, Lipsky JJ. Methylphenidate: Its pharmacology and uses. Mayo Clin Proc. 2000;75:711–21. - PubMed
    1. Rappley MD. Safety issues in the use of methylphenidate: An American perspective. Drug Saf. 1997;17:143–8. - PubMed
    1. Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. J Neurochem. 1997;68:2032–7. - PubMed
    1. Ruggiero S, Rafaniello C, Bravaccio C, Grimaldi G, Granato R, Pascotto A, et al. Safety of attention-deficit/hyperactivity disorder medications in children: An intensive pharmacosurveillance monitoring study. J Child Adolesc Psychopharmacol. 2012;22:415–22. - PubMed
    1. Hesapcioglu ST, Goker Z, Bilginer C, Kandil S. Methylphenidate ınduced psychotic symptoms: Two cases report. J Med Cases. 2013;4:106–8.